Editorial: 'Engineering the Tumor Immune Microenvironment' Special Issue
| dc.contributor.author | Ahmad, Raffae N. | en |
| dc.contributor.author | Verbridge, Scott S. | en |
| dc.date.accessioned | 2023-08-25T12:57:59Z | en |
| dc.date.available | 2023-08-25T12:57:59Z | en |
| dc.date.issued | 2023-08-08 | en |
| dc.date.updated | 2023-08-25T12:37:02Z | en |
| dc.description.abstract | Cancer immunotherapies, while promising and occasionally even curative, encounter numerous hurdles within the tumor microenvironment that hinder their efficacy [...] | en |
| dc.description.version | Published version | en |
| dc.format.mimetype | application/pdf | en |
| dc.identifier.citation | Ahmad, R.N.; Verbridge, S.S. Editorial: 'Engineering the Tumor Immune Microenvironment' Special Issue. Cancers 2023, 15, 4014. | en |
| dc.identifier.doi | https://doi.org/10.3390/cancers15164014 | en |
| dc.identifier.uri | http://hdl.handle.net/10919/116123 | en |
| dc.language.iso | en | en |
| dc.publisher | MDPI | en |
| dc.rights | Creative Commons Attribution 4.0 International | en |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en |
| dc.title | Editorial: 'Engineering the Tumor Immune Microenvironment' Special Issue | en |
| dc.title.serial | Cancers | en |
| dc.type | Article | en |
| dc.type.dcmitype | Text | en |